The global respiratory inhalers market is poised for a significant breath of fresh air, with a projected valuation of US$ 60,114.7 million by 2033. This represents a robust Compound Annual Growth Rate (CAGR) of 4.90%, building upon a strong foundation of US$ 37,258.5 million in 2023. Several key factors are driving this market expansion. Firstly, …